איבופרו פורטה 400

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Compra

Foglio illustrativo Foglio illustrativo (PIL)
21-10-2018

Principio attivo:

IBUPROFEN

Commercializzato da:

DEXCEL LTD, ISRAEL

Codice ATC:

M01AE01

Forma farmaceutica:

קפליות

Composizione:

IBUPROFEN 400 MG

Via di somministrazione:

פומי

Tipo di ricetta:

אין צורך במרשם

Prodotto da:

DEXCEL LTD, ISRAEL

Gruppo terapeutico:

IBUPROFEN

Area terapeutica:

IBUPROFEN

Indicazioni terapeutiche:

For the relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. For the relief of mild to moderate pain and treatment of primary dysmenorrhea.For the treatment of pain associated with migraine.

Data dell'autorizzazione:

2023-03-31

Foglio illustrativo

                                " )
(
-
1986
200 /
400 ,
200
(
Ibuprofen
)
200
.
"
400
(
Ibuprofen
)
400
."
-
6
"
"
2
"
"
.
.
.
.
,
,
12
.
.
3
"
?
"
.
.
,
)
(
10
3
(
12-18
)
.
1
.
?
200 /
400
;
,
,
,
,
:
.)
(
200
. :
(
NSAIDs
)
.
.
,
2
.
:

)
(
,)
(
(
6
)
(
NSAIDs
)
.

-
NSAIDs
.

(
2
)
.

(
,
,
,]
[
)
,
(
-
NSAIDs
.)

12
.

.

"
(
,
.)"
:
200 /
400 ,
:

.

.

,
,
,
,
(
)
,
"
(
-
"
–
"
TIA
"
.)

(
.)

,
,
.
2

.
,

(
)
.

65
,
.

.

(
Varicella
.)

,
,
.
.
,
.
,
.

.
.
:

/
,
,
,
.
.

.
,
,
,
,
.
4
.
:
, ,
.
:

NSAIDs
:
(
COX-2
[
COX-2 inhibitors
]
)

(
)
.

.

(
SSRIs
,)
.

,
NSAIDs
.

(
)
.

(
)
.

.)
(

.)
(

(
.)

)
(
.

:
HIV(+)
.

(
)
–
NSAIDs
.

(
,
)
,
.

:
(
,)
ACE
(
)
II
(
)
.

.)
( .
.
3
.
: ,

.
.
.
.
,

20
.
-
NSAIDs
20
.

-
6
.
-
3
.

-
.
,
.
.
.
-
1
(
23
) "
."
"
,
3
.
?
. :
12
:
200
:
1-2
,
3
.
4
.
-
6
-
24
.
400
:
3
.
4
.
-
3
-
24
.
12
.
.
(
12-18
)
–
-
3
.
–
-
10
.
,
.
(
,
,
)
.
)
(
–
(
2
.)
:
.
.
.
,
,
.
,
,
,)
(
,
,
.
,
,
,
,)
(
,
4
.
,
,
,
.
.
!
.
. ,
.
4
.
,
200 /
400
.
.
.
:

(
/
)

:
,
-
'
.

DRESS
(
.)
DRESS
,
,
:
.)
(

,
,
(
,
,
,
AGEP
.)
.
2
. :

,
,
.
,
,
,

.
)
(

.

.

,
,
,
.

,
,
,
,
,
.

,
,
,
,
,
.)
(

,
.

,
,
,
,)
(
.

(
–
.)

(
Varicella
.)

.
.

200 /
400
.
)
(

.

.
)
'
(
NSAIDs
.
.
,
,
NSAIDs
5
.
,
.
. ,
,
.
"
"
(
www.health.gov.il
)
,
:
https://sideeffects.health.gov.il/
5
.
?

!
/
.
.

.
.

:
,
-
°C
25
.

.
.
,
6
.
:
200
:
Microcrystalline cellulose, maize starch, croscarmellose sodium,
magnesium
stearate, hypromellose, carmellose sodium, silica colloidal anhydrous,
talc, stearic
acid, titanium dioxide (E-171), erythrosine aluminium lake (E-127),
macrogol 400,
carnauba wax, quinoline yellow aluminium lake (E-104), brilliant blue
FCF aluminium
lake E-133.
400
:
Microcrystalline cellulose, maize starch, croscarmellose sodium,
magnesium
stearate, carmellose sodium, silica colloidal anhydrous, hypromellose
                                
                                Leggi il documento completo
                                
                            

Documenti in altre lingue

Foglio illustrativo Foglio illustrativo inglese 21-10-2018
Scheda tecnica Scheda tecnica inglese 21-10-2018
Foglio illustrativo Foglio illustrativo arabo 21-10-2018

Cerca alert relativi a questo prodotto